Literature DB >> 19454459

Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

S Jelic1.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19454459     DOI: 10.1093/annonc/mdp124

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.

Authors:  Rodolfo Sacco; Lorenzo Faggioni; Irene Bargellini; Antonio Romano; Marco Bertini; Barbara Ginanni; Valentina Battaglia; Michele Bertoni; Elena Bozzi; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Neri; Elisabetta Sodini; Emanuele Tumino; Giampaolo Bresci; Carlo Bartolozzi
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 2.  Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients.

Authors:  Rodolfo Sacco; Valeria Mismas; Antonio Romano; Marco Bertini; Michele Bertoni; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Tumino; Giampaolo Bresci; Luca Giacomelli; Sara Marceglia; Irene Bargellini
Journal:  World J Hepatol       Date:  2015-01-27

3.  Successful resection of hepatocellular cancer not amenable to Milan criteria and durable complete remission induced by systemic polichemotherapy after development of metastases - should we think about revising the current treatment guidelines in selected patients?

Authors:  Ivana Rados; Sasa Badzek; Hilda Golem; Juraj Prejac; Irma Gorsic; Domina Kekez; Niksa Librenjak; Stjepko Plestina
Journal:  World J Surg Oncol       Date:  2013-09-22       Impact factor: 2.754

4.  Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo.

Authors:  Lejla Hasanbegovic; Nedeljka Sljivo
Journal:  Mater Sociomed       Date:  2018-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.